Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Oscier

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
British Journal of Haematology|May 7, 2016
The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trialDavid Oscier, Monica Else, Estella Matutes, et al.
Scientific Reports|July 20, 2019
Systematic Review of Somatic Mutations in Splenic Marginal Zone LymphomaCarolina Jaramillo Oquendo, Helen Parker, David Oscier, et al.
British Journal of Haematology|January 25, 2003
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromesDavid Bowen, Dominic Culligan, Simon Jowitt, et al.
Haematologica|August 5, 2005
ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemiaMartin Corcoran, Anton Parker, Jenny Orchard, et al.
Journal of Cellular and Molecular Medicine|December 14, 2011
Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLLShilu Amin, Meagan Walsh, Caroline Wilson, et al.
Cancer Genetics|September 3, 2014
Translocation t(2;7)(p11.2;q21.2): a rare genetic aberration associated with B-cell lymphoproliferative disorders of marginal-zone originAliki Xochelli, Panagiotis Baliakas, Sarah Moore, et al.
Leukemia Research|September 30, 2011
A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemiaAnne Gardiner, Helen Parker, Sharron Glide, et al.
Haematologica|June 1, 2010
Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocationDavid Oscier, Rachel Wade, Zadie Davis, et al.
Nature Communications|June 28, 2016
Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networksAndré F Rendeiro, Christian Schmidl, Jonathan C Strefford, et al.
British Journal of Haematology|November 20, 2008
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemiaGuy Pratt, Stephen Harding, Roger Holder, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|May 7, 2016
The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trialDavid Oscier, Monica Else, Estella Matutes, et al.
Scientific Reports|July 20, 2019
Systematic Review of Somatic Mutations in Splenic Marginal Zone LymphomaCarolina Jaramillo Oquendo, Helen Parker, David Oscier, et al.
British Journal of Haematology|January 25, 2003
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromesDavid Bowen, Dominic Culligan, Simon Jowitt, et al.
Haematologica|August 5, 2005
ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemiaMartin Corcoran, Anton Parker, Jenny Orchard, et al.
Journal of Cellular and Molecular Medicine|December 14, 2011
Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLLShilu Amin, Meagan Walsh, Caroline Wilson, et al.
Cancer Genetics|September 3, 2014
Translocation t(2;7)(p11.2;q21.2): a rare genetic aberration associated with B-cell lymphoproliferative disorders of marginal-zone originAliki Xochelli, Panagiotis Baliakas, Sarah Moore, et al.
Leukemia Research|September 30, 2011
A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemiaAnne Gardiner, Helen Parker, Sharron Glide, et al.
Haematologica|June 1, 2010
Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocationDavid Oscier, Rachel Wade, Zadie Davis, et al.
Nature Communications|June 28, 2016
Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networksAndré F Rendeiro, Christian Schmidl, Jonathan C Strefford, et al.
British Journal of Haematology|November 20, 2008
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemiaGuy Pratt, Stephen Harding, Roger Holder, et al.
Pageof 10